Gly-β-MCA, a bile acid, is a potent, sable, intestine-selective and oral bioactive farnesoid X receptor (FXR) inhibitor that may be a candidate for the treatment of metabolic disorders.
IC50&Target
FXR.
体外研究
Gly-β-MCA, a bile acid, is a potent, sable and intestine-selective and farnesoid X receptor (FXR) inhibitor.
Gly-β-MCA (Gly-MCA, ) is resistant to hydrolysis by BSH.
体内研究
Gly-β-MCA (Gly-MCA, p.o. 10 and 50 mg/kg) prevents and treats diet-induced and genetic obesity, along with insulin resistance and hepatic steatosis without systemic, hepatic or intestinal toxicities in mice.
Gly-MCA does not increase faecal LCN-2 levels, indicating that Gly-MCA does not induce intestinal inflammation.
分子式
C26H43NO6
分子量
465.62
CAS号
66225-78-3
运输条件
Room temperature in continental US; may vary elsewhere.